Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Binimetinib bulk supplier for pharma manufacturers

Binimetinib 15 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 15 mg

Reference Brands: Mektovi (USA/EU)

Category: Oncology Cancer Care

Binimetinib is a MEK inhibitor used in targeted cancer therapy. It works by blocking MEK1/MEK2 enzymes in the MAPK pathway, helping slow down the growth of cancer cells. It is commonly used along with encorafenib for cancers with BRAF mutation.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Binimetinib — third party manufacturing & bulk supply

Binimetinib 15 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Binimetinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Binimetinib →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Binimetinib is used to treat certain cancers, including unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and in combination with other drugs for some non-small cell lung cancers with BRAF mutations.

Binimetinib is a small-molecule MEK1/2 inhibitor that blocks the activity of MEK enzymes in the MAPK/ERK signaling pathway, which helps prevent cancer cells from multiplying.

The trade name is Mektovi.

It is manufactured and marketed by Array BioPharma Inc., a subsidiary of Pfizer, under the trade name Mektovi.

The generic name is binimetinib.

The brand name is Mektovi.

Binimetinib tablets are produced in pharmaceutical manufacturing facilities in the United States under standard regulatory practices.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.